Literature DB >> 15175026

Dystroglycan in skin and cutaneous cells: beta-subunit is shed from the cell surface.

Christine Herzog1, Cristina Has, Claus-Werner Franzke, Frank G Echtermeyer, Ursula Schlötzer-Schrehardt, Stephan Kröger, Erika Gustafsson, Reinhard Fässler, Leena Bruckner-Tuderman.   

Abstract

In skin, hemidesmosomal protein complexes attach the epidermis to the dermis and are critical for stable connection of the basal epithelial cell cytoskeleton with the basement membrane (BM). In muscle, a similar supramolecular aggregate, the dystrophin glycoprotein complex links the inside of muscle cells with the BM. A component of the muscle complex, dystroglycan (DG), also occurs in epithelia. In this study, we characterized the expression and biochemical properties of authentic and recombinant DG in human skin and cutaneous cells in vitro. We show that DG is present at the epidermal BM zone, and it is produced by both keratinocytes and fibroblasts in vitro. The biosynthetic precursor is efficiently processed to the alpha- and beta-DG subunits; and, in addition, a distinct extracellular segment of the transmembranous beta-subunit is shed from the cell surface by metalloproteinases. Shedding of the beta-subunit releases the alpha-subunit from the DG complex on the cell surface into the extracellular space. The shedding is enhanced by IL-1beta and phorbol esters, and inhibited by metalloproteinase inhibitors. Deficiency of perlecan, a major ligand of alpha-DG, enhanced shedding suggesting that lack of a binding partner destabilizes the epithelial DG complex and makes it accessible to proteolytic processing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175026     DOI: 10.1111/j.0022-202X.2004.22605.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

1.  Perlecan and Dystroglycan act at the basal side of the Drosophila follicular epithelium to maintain epithelial organization.

Authors:  Martina Schneider; Ashraf A Khalil; John Poulton; Casimiro Castillejo-Lopez; Diane Egger-Adam; Andreas Wodarz; Wu-Min Deng; Stefan Baumgartner
Journal:  Development       Date:  2006-08-30       Impact factor: 6.868

Review 2.  Laminins in Epithelial Cell Polarization: Old Questions in Search of New Answers.

Authors:  Karl S Matlin; Satu-Marja Myllymäki; Aki Manninen
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-10-03       Impact factor: 10.005

3.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Authors:  Elizabeth Stevens; Keren J Carss; Sebahattin Cirak; A Reghan Foley; Silvia Torelli; Tobias Willer; Dimira E Tambunan; Shu Yau; Lina Brodd; Caroline A Sewry; Lucy Feng; Goknur Haliloglu; Diclehan Orhan; William B Dobyns; Gregory M Enns; Melanie Manning; Amanda Krause; Mustafa A Salih; Christopher A Walsh; Matthew Hurles; Kevin P Campbell; M Chiara Manzini; Derek Stemple; Yung-Yao Lin; Francesco Muntoni
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

4.  The rapid decrease in astrocyte-associated dystroglycan expression by focal cerebral ischemia is protease-dependent.

Authors:  Richard Milner; Stephanie Hung; Xiaoyun Wang; Maria Spatz; Gregory J del Zoppo
Journal:  J Cereb Blood Flow Metab       Date:  2007-11-21       Impact factor: 6.200

5.  MMP2-9 cleavage of dystroglycan alters the size and molecular composition of Schwann cell domains.

Authors:  Felipe A Court; Desirée Zambroni; Ernesto Pavoni; Cristina Colombelli; Chiara Baragli; Gianluca Figlia; Lydia Sorokin; William Ching; James L Salzer; Lawrence Wrabetz; M Laura Feltri
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

6.  Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy.

Authors:  Camilla Pellegrini; Alessandra Zulian; Francesca Gualandi; Elisa Manzati; Luciano Merlini; Maria E Michelini; Luisa Benassi; Sandra Marmiroli; Alessandra Ferlini; Patrizia Sabatelli; Paolo Bernardi; Nadir M Maraldi
Journal:  J Cell Physiol       Date:  2013-06       Impact factor: 6.384

Review 7.  Skin basement membrane: the foundation of epidermal integrity--BM functions and diverse roles of bridging molecules nidogen and perlecan.

Authors:  Dirk Breitkreutz; Isabell Koxholt; Kathrin Thiemann; Roswitha Nischt
Journal:  Biomed Res Int       Date:  2013-03-21       Impact factor: 3.411

8.  Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients.

Authors:  Claudio Coco; Gian Franco Zannoni; Emanuele Caredda; Stefano Sioletic; Alma Boninsegna; Mario Migaldi; Gianluca Rizzo; Luca Reggiani Bonetti; Giannicola Genovese; Egidio Stigliano; Achille Cittadini; Alessandro Sgambato
Journal:  J Exp Clin Cancer Res       Date:  2012-09-11

9.  Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis.

Authors:  Smriti Agrawal; Per Anderson; Madeleine Durbeej; Nico van Rooijen; Fredrik Ivars; Ghislain Opdenakker; Lydia M Sorokin
Journal:  J Exp Med       Date:  2006-04-03       Impact factor: 14.307

10.  Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.

Authors:  Keren J Carss; Elizabeth Stevens; A Reghan Foley; Sebahattin Cirak; Moniek Riemersma; Silvia Torelli; Alexander Hoischen; Tobias Willer; Monique van Scherpenzeel; Steven A Moore; Sonia Messina; Enrico Bertini; Carsten G Bönnemann; Jose E Abdenur; Carla M Grosmann; Akanchha Kesari; Jaya Punetha; Ros Quinlivan; Leigh B Waddell; Helen K Young; Elizabeth Wraige; Shu Yau; Lina Brodd; Lucy Feng; Caroline Sewry; Daniel G MacArthur; Kathryn N North; Eric Hoffman; Derek L Stemple; Matthew E Hurles; Hans van Bokhoven; Kevin P Campbell; Dirk J Lefeber; Yung-Yao Lin; Francesco Muntoni
Journal:  Am J Hum Genet       Date:  2013-06-13       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.